-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Downgrades Mereo BioPharma Group to Hold, Lowers Price Target to $0.5

Benzinga·12/30/2025 12:41:00
Listen to the news
Jefferies analyst Maury Raycroft downgrades Mereo BioPharma Group (NASDAQ:MREO) from Buy to Hold and lowers the price target from $7 to $0.5.